Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of Helicobacter pylori

Gastric acid inhibition during treatment is important for the eradication of Helicobacter pylori (H. pylori) infection. A novel potassium-competitive acid blocker, vonoprazan (VPZ), has been demonstrated to achieve high eradication rates; however, the efficacy of second-line treatment in failures of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biomed Rep
Egile Nagusiak: Mori, Naoyoshi, Nishiura, Yuuki, Suga, Daisuke, Moritani, Isao, Yamanaka, Yutaka, Ooya, Yumi, Inoue, Hidekazu, Takase, Koujirou, Hioki, Masato, Shiraki, Katsuya
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2018
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6036823/
https://ncbi.nlm.nih.gov/pubmed/30013779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2018.1111
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak